Stereotaxis (Stereotaxis) EPS (Basic) : $-0.27 (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Stereotaxis EPS (Basic)?

Stereotaxis's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was $-0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.27.

Stereotaxis's EPS (Diluted) for the three months ended in Dec. 2023 was $-0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.27.

Stereotaxis's EPS without NRI for the three months ended in Dec. 2023 was $-0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.27.

During the past 3 years, the average EPS without NRI Growth Rate was -34.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -50.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 18.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Stereotaxis's highest 3-Year average EPS without NRI Growth Rate was 64.60% per year. The lowest was -84.70% per year. And the median was 31.70% per year.

Stereotaxis EPS (Basic) Historical Data

The historical data trend for Stereotaxis's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stereotaxis EPS (Basic) Chart

Stereotaxis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.10

-0.11

-0.16

-0.26

-0.27

Stereotaxis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.06	-0.07	-0.07	-0.07	-0.06

Stereotaxis EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Stereotaxis's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-20.713	-	1.343)	/	80.702
	=	-0.27

Stereotaxis's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.04	-	0.339)	/	82.725
	=	-0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.27

Stereotaxis (AMEX:STXS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Stereotaxis EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Stereotaxis's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Stereotaxis (Stereotaxis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stereotaxis Inc (AMEX:STXS) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

RJR1:Germany

Address

710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101

Website

https://www.stereotaxis.com

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.

Executives

Paul J Isaac	10 percent owner	530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Myriam Curet	director	1020 KIFER ROAD, SUNNYVALE CA 94086
David Benfer	director	5 SELDEN AVENUE, BRANFORD CT 06404
Kimberly R. Peery	officer: Chief Financial Officer	C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE: SUITE 100, ST. LOUIS MO 63108
Kevin M. Barry	officer: Chief Legal Officer & Secretar	4320 FOREST PARK AVENUE, 100, ST. LOUIS MO 63108
Ross B Levin	director	530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Fariba Fischel Ghodsian	10 percent owner	10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Dafna Capital Management Llc	10 percent owner	10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
David Leo Fischel	director	10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Arun Swarup Menawat	director	2412 EIGHTH LINE, OAKVILLE A6 L6H6S9
Joe E Kiani	director	4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Brathwaite	officer: VP Research & Development	C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Martin C Stammer	officer: Chief Financial Officer	C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Nathan Fischel	director	10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Duane Desisto	director	C/O INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730